Yoav Gal

586 total citations
31 papers, 436 citations indexed

About

Yoav Gal is a scholar working on Immunology, Biotechnology and Infectious Diseases. According to data from OpenAlex, Yoav Gal has authored 31 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 11 papers in Biotechnology and 4 papers in Infectious Diseases. Recurrent topics in Yoav Gal's work include Toxin Mechanisms and Immunotoxins (23 papers), Transgenic Plants and Applications (11 papers) and Herbal Medicine Research Studies (4 papers). Yoav Gal is often cited by papers focused on Toxin Mechanisms and Immunotoxins (23 papers), Transgenic Plants and Applications (11 papers) and Herbal Medicine Research Studies (4 papers). Yoav Gal collaborates with scholars based in Israel, Italy and Canada. Yoav Gal's co-authors include Chanoch Kronman, Tamar Sabo, Anita Sapoznikov, Reut Falach, Ohad Mazor, Sharon Ehrlich, Ron Alcalay, Moshe Aftalion, Arik Makovitzki and Irit Sagi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Yoav Gal

31 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoav Gal Israel 12 305 165 109 64 45 31 436
Reut Falach Israel 11 288 0.9× 149 0.9× 107 1.0× 31 0.5× 42 0.9× 28 369
Eyal Epstein Israel 13 121 0.4× 69 0.4× 143 1.3× 8 0.1× 11 0.2× 27 356
Ryotaro Ishimitsu Japan 8 237 0.8× 138 0.8× 119 1.1× 9 0.1× 20 0.4× 13 510
Xuefeng Li China 11 83 0.3× 18 0.1× 150 1.4× 39 0.6× 15 0.3× 43 384
Melinda Przetak United States 8 392 1.3× 63 0.4× 224 2.1× 30 0.5× 2 0.0× 12 626
Xiaolong Tang China 12 63 0.2× 19 0.1× 197 1.8× 25 0.4× 25 0.6× 29 425
Anne E. Geller United States 7 223 0.7× 36 0.2× 93 0.9× 19 0.3× 11 0.2× 14 420
Marni E. Cueno Japan 14 71 0.2× 24 0.1× 218 2.0× 26 0.4× 8 0.2× 44 582
Iñigo Angulo Spain 9 342 1.1× 15 0.1× 67 0.6× 9 0.1× 18 0.4× 14 534

Countries citing papers authored by Yoav Gal

Since Specialization
Citations

This map shows the geographic impact of Yoav Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoav Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoav Gal more than expected).

Fields of papers citing papers by Yoav Gal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoav Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoav Gal. The network helps show where Yoav Gal may publish in the future.

Co-authorship network of co-authors of Yoav Gal

This figure shows the co-authorship network connecting the top 25 collaborators of Yoav Gal. A scholar is included among the top collaborators of Yoav Gal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoav Gal. Yoav Gal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aloni-Grinstein, Ronit, Emanuelle Mamroud, & Yoav Gal. (2025). New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections. Microorganisms. 13(9). 2115–2115. 1 indexed citations
2.
Gal, Yoav, Anita Sapoznikov, Shlomi Lazar, et al.. (2024). Long-Term Pulmonary Damage in Surviving Antitoxin-Treated Mice following a Lethal Ricin Intoxication. Toxins. 16(2). 103–103. 2 indexed citations
3.
Gal, Yoav, Hadar Marcus, Emanuelle Mamroud, & Ronit Aloni-Grinstein. (2023). Mind the Gap—A Perspective on Strategies for Protecting against Bacterial Infections during the Period from Infection to Eradication. Microorganisms. 11(7). 1701–1701. 4 indexed citations
4.
Gal, Yoav, et al.. (2022). Low serological rate of SARS-CoV-2 in cats from military bases in Israel. Comparative Immunology Microbiology and Infectious Diseases. 90-91. 101905–101905. 2 indexed citations
5.
Sapoznikov, Anita, Yoav Gal, Ron Alcalay, et al.. (2022). Characterization of Lung Injury following Abrin Pulmonary Intoxication in Mice: Comparison to Ricin Poisoning. Toxins. 14(9). 614–614. 2 indexed citations
6.
Korach-Rechtman, Hila, Galoz Kaneti, Igor Nudelman, et al.. (2022). Lung targeted liposomes for treating ARDS. Journal of Controlled Release. 346. 421–433. 58 indexed citations
7.
Gal, Yoav, et al.. (2021). Potential Prophylactic Treatments for COVID-19. Viruses. 13(7). 1292–1292. 7 indexed citations
8.
Falach, Reut, Pinchas Halpern, Anita Sapoznikov, et al.. (2021). Pathophysiological profile of awake and anesthetized pigs following systemic exposure to the highly lethal ricin toxin. Clinical Toxicology. 60(1). 76–82. 3 indexed citations
9.
Falach, Reut, Anita Sapoznikov, Yoav Gal, et al.. (2020). The low density receptor-related protein 1 plays a significant role in ricin-mediated intoxication of lung cells. Scientific Reports. 10(1). 9007–9007. 2 indexed citations
10.
Gal, Yoav, Anita Sapoznikov, Reut Falach, et al.. (2020). Equal Neutralization Potency of Antibodies Raised against Abrin Subunits. SHILAP Revista de lepidopterología. 9(1). 4–4. 4 indexed citations
11.
Mechaly, Adva, Ron Alcalay, Tal Noy-Porat, et al.. (2018). Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication. Toxins. 10(2). 80–80. 12 indexed citations
12.
13.
Falach, Reut, Anita Sapoznikov, Ron Alcalay, et al.. (2018). Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin. Toxins. 10(11). 466–466. 10 indexed citations
14.
Gal, Yoav, Ohad Mazor, Reut Falach, et al.. (2017). Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future Prospects. Toxins. 9(10). 311–311. 39 indexed citations
15.
Falach, Reut, Anita Sapoznikov, Yoav Gal, et al.. (2016). Quantitative profiling of the in vivo enzymatic activity of ricin reveals disparate depurination of different pulmonary cell types. Toxicology Letters. 258. 11–19. 29 indexed citations
16.
Gal, Yoav, Anita Sapoznikov, Reut Falach, et al.. (2016). Potent Antiedematous and Protective Effects of Ciprofloxacin in Pulmonary Ricinosis. Antimicrobial Agents and Chemotherapy. 60(12). 7153–7158. 17 indexed citations
17.
Gal, Yoav, Ron Alcalay, Tamar Sabo, et al.. (2015). Rapid assessment of antibody-induced ricin neutralization by employing a novel functional cell-based assay. Journal of Immunological Methods. 424. 136–139. 11 indexed citations
18.
Sabo, Tamar, Yoav Gal, Anita Sapoznikov, et al.. (2015). Antibody treatment against pulmonary exposure to abrin confers significantly higher levels of protection than treatment against ricin intoxication. Toxicology Letters. 237(2). 72–78. 22 indexed citations
19.
Gal, Yoav, Ohad Mazor, Ron Alcalay, et al.. (2014). Antibody/doxycycline combined therapy for pulmonary ricinosis: Attenuation of inflammation improves survival of ricin-intoxicated mice. Toxicology Reports. 1. 496–504. 42 indexed citations
20.
Gal, Yoav, et al.. (1994). Heart-lung protection from ischemic injury during 8 hour hypothermic preservation.. PubMed. 65(3-4). 181–98. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reut Falach Breakdown of academic impact, for papers by Eyal Epstein Breakdown of academic impact, for papers by Ryotaro Ishimitsu Breakdown of academic impact, for papers by Xuefeng Li Breakdown of academic impact, for papers by Melinda Przetak Breakdown of academic impact, for papers by Xiaolong Tang Breakdown of academic impact, for papers by Anne E. Geller Breakdown of academic impact, for papers by Marni E. Cueno Breakdown of academic impact, for papers by Iñigo Angulo
Rankless by CCL
2026